サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1542793

医薬品グレードの塩化ナトリウムの世界市場

Pharmaceutical Grade Sodium Chloride
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 102 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
医薬品グレードの塩化ナトリウムの世界市場
出版日: 2024年08月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 102 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

医薬品グレードの塩化ナトリウムの世界市場は2030年までに9億7,370万米ドルに達する見込み

2023年に6億6,480万米ドルと推定された医薬品グレードの塩化ナトリウムの世界市場は、2030年には9億7,370万米ドルに達し、分析期間2023-2030年のCAGRは5.6%で成長すると予測されます。本レポートで分析したセグメントの1つである透析エンドユーズは、CAGR 6.0％を記録し、分析期間終了時には4億1,750万米ドルに達すると予測されます。注射エンドユーズ分野の成長率は、分析期間中CAGR 6.3％と推定されます。

米国市場は1億7,930万米ドルと推定、中国はCAGR 5.1％で成長予測

米国の医薬品グレードの塩化ナトリウム市場は、2023年に1億7,930万米ドルと推定されます。世界第2位の経済大国である中国は、2023-2030年のCAGRを5.1%として、2030年までに1億5,150万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.8%と4.6%と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界の医薬品グレードの塩化ナトリウム市場- 主要動向と促進要因のまとめ

純度の確保：医薬品グレードの塩化ナトリウムの重要な役割

一般的に食塩として知られる医薬品グレードの塩化ナトリウムは、医療・医薬用途に使用される塩化ナトリウムを高度に精製したものです。通常の食卓塩とは異なり、このグレードの塩化ナトリウムには汚染物質や不純物が含まれていないため、繊細な用途における安全性と有効性が保証されています。塩化ナトリウムは、静脈内生理食塩水、経口補水塩、注射剤の希釈剤など、様々な医薬製剤において重要な役割を果たしています。医薬品グレードの塩化ナトリウムの純度と一貫性は、医薬品が厳しい規制基準を満たし、効果的な治療を提供できるようにするために最も重要です。その用途は透析液、創傷ケア製品、さらには鼻洗浄剤にまで及び、その多用途性と現代ヘルスケアにおける不可欠性を際立たせています。

技術の進歩はどのように医薬用塩化ナトリウムの品質を高めているのか？

技術の進歩は、医薬品グレードの塩化ナトリウムの生産と品質管理を大幅に改善しました。再結晶や膜ろ過などの高度な精製技術により、不純物の除去が強化され、世界中の薬局方の厳しい基準を満たす高純度の塩化ナトリウムが確保されています。高速液体クロマトグラフィー（HPLC）や原子吸光分析（AAS）などの高度な分析法の導入により、不純物レベルの正確なモニタリングが可能になり、一貫性と安全性が確保されています。さらに、製造工程の自動化により、人的ミスが最小限に抑えられ、生産効率が向上しています。このような技術の進歩は、医薬用塩化ナトリウムの高品質を保証するだけでなく、ヘルスケア分野における需要の高まりに対応するための大量生産を可能にしています。

医薬用塩化ナトリウムを管理する規制と安全基準は？

医薬品グレードの塩化ナトリウムは、医療用としての適合性を確保するため、厳格な規制・安全基準に従っています。米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの規制機関は、この重要な成分の製造、試験、表示について厳格なガイドラインを課しています。米国薬局方（USP）や欧州薬局方（Ph.Eur.）などの薬局方規格の遵守が義務付けられています。これらの規格は、不純物の許容レベル、微生物限界、要求される物理的・化学的特性を規定しています。製造業者はまた、品質管理システム、衛生基準、文書化手順を包含する適正製造規範（GMP）を遵守しなければならないです。このような厳しい規制を遵守することで、医薬品グレードの塩化ナトリウムが医療用途に安全に使用され、最高の品質基準を満たしていることが保証されます。

医薬品グレードの塩化ナトリウム市場の成長を促進する要因は？

医薬品グレードの塩化ナトリウム市場の成長は、いくつかの要因によって牽引されています。まず、糖尿病や腎臓病などの慢性疾患の増加により、高純度の塩化ナトリウムが不可欠な静脈生理食塩水や透析治療の需要が高まっています。精製・製造プロセスの技術的進歩が製品の品質を高め、生産能力を拡大し、高まるヘルスケア・ニーズに応えています。また、世界の高齢化により、医薬品グレードの塩化ナトリウムを利用した様々な治療に対する需要が高まっています。医薬品の製剤化と生産に高品質の原料を必要とするバイオ医薬品分野の拡大は、市場の成長をさらに促進しています。さらに、厳しい規制基準により、メーカーは生産プロセスや品質管理を継続的に改善し、安全で効果的な医薬品グレードの塩化ナトリウムの供給を確保しています。最後に、個別化医療と先進ドラッグデリバリーシステムへの注目の高まりが、医薬用塩化ナトリウムの特殊用途に新たな機会を生み出し、市場拡大に拍車をかけています。

調査対象企業の例（注目の12社）

  • Akzo Nobel NV
  • Dominion Salt Ltd.
  • Hebei Huachen Pharmaceutical Co., Ltd.
  • K+S France S.A.S.
  • Morton Salt, Inc.
  • Salinen Austria Aktiengesellschaft
  • Sudwestdeutsche Salzwerke AG
  • Swiss Saltworks
  • Tianjin Changlu Haijing Group Co., Ltd.
  • US Salt, LLC.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13957

Global Pharmaceutical Grade Sodium Chloride Market to Reach US$973.7 Million by 2030

The global market for Pharmaceutical Grade Sodium Chloride estimated at US$664.8 Million in the year 2023, is expected to reach US$973.7 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Dialysis End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$417.5 Million by the end of the analysis period. Growth in the Injections End-Use segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$179.3 Million While China is Forecast to Grow at 5.1% CAGR

The Pharmaceutical Grade Sodium Chloride market in the U.S. is estimated at US$179.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$151.5 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Pharmaceutical Grade Sodium Chloride Market - Key Trends and Drivers Summarized

Ensuring Purity: The Essential Role of Pharmaceutical Grade Sodium Chloride

Pharmaceutical grade sodium chloride, commonly known as salt, is a highly purified form of sodium chloride used in medical and pharmaceutical applications. Unlike regular table salt, this grade of sodium chloride is free from contaminants and impurities, ensuring its safety and efficacy in sensitive applications. It plays a critical role in various pharmaceutical formulations, including intravenous (IV) saline solutions, oral rehydration salts, and as a diluent for injectable drugs. The purity and consistency of pharmaceutical grade sodium chloride are paramount as they ensure that medications meet stringent regulatory standards and provide effective treatment. Its use extends to dialysis solutions, wound care products, and even as a nasal rinse, highlighting its versatility and indispensability in modern healthcare.

How Are Technological Advancements Enhancing the Quality of Pharmaceutical Sodium Chloride?

Technological advancements have significantly improved the production and quality control of pharmaceutical grade sodium chloride. Advanced purification techniques, such as recrystallization and membrane filtration, have enhanced the removal of impurities, ensuring high-purity sodium chloride that meets the stringent standards of pharmacopeias worldwide. The implementation of sophisticated analytical methods, including high-performance liquid chromatography (HPLC) and atomic absorption spectroscopy (AAS), allows for precise monitoring of impurity levels, ensuring consistency and safety. Furthermore, automation in manufacturing processes has minimized human error and increased production efficiency. These technological strides not only ensure the high quality of pharmaceutical sodium chloride but also enable large-scale production to meet the growing demand in the healthcare sector.

What Are the Regulatory and Safety Standards Governing Pharmaceutical Sodium Chloride?

Pharmaceutical grade sodium chloride is subject to rigorous regulatory and safety standards to ensure its suitability for medical use. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict guidelines on the production, testing, and labeling of this critical ingredient. Compliance with pharmacopeial standards, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), is mandatory. These standards specify the acceptable levels of impurities, microbial limits, and the required physical and chemical properties. Manufacturers must also adhere to Good Manufacturing Practices (GMP), which encompass quality management systems, hygiene standards, and documentation procedures. The adherence to these stringent regulations ensures that pharmaceutical grade sodium chloride is safe for use in medical applications and meets the highest quality standards.

What Factors Are Driving Growth in the Pharmaceutical Grade Sodium Chloride Market?

The growth in the pharmaceutical grade sodium chloride market is driven by several factors. Firstly, the increasing prevalence of chronic diseases such as diabetes and kidney disorders is boosting the demand for IV saline solutions and dialysis treatments, where high-purity sodium chloride is essential. Technological advancements in purification and manufacturing processes are enhancing product quality and expanding production capacity, meeting the rising healthcare needs. Additionally, the aging global population is contributing to higher demand for various medical treatments that utilize pharmaceutical grade sodium chloride. The expansion of the biopharmaceutical sector, which requires high-quality raw materials for drug formulation and production, is further propelling market growth. Furthermore, stringent regulatory standards are driving manufacturers to continuously improve their production processes and quality controls, ensuring the supply of safe and effective pharmaceutical grade sodium chloride. Lastly, the increasing focus on personalized medicine and advanced drug delivery systems is creating new opportunities for specialized applications of pharmaceutical sodium chloride, fueling market expansion.

Select Competitors (Total 12 Featured) -

  • Akzo Nobel NV
  • Dominion Salt Ltd.
  • Hebei Huachen Pharmaceutical Co., Ltd.
  • K+S France S.A.S.
  • Morton Salt, Inc.
  • Salinen Austria Aktiengesellschaft
  • Sudwestdeutsche Salzwerke AG
  • Swiss Saltworks
  • Tianjin Changlu Haijing Group Co., Ltd.
  • US Salt, LLC.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Pharmaceutical Grade Sodium Chloride - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Injectable Drugs Drives Market Growth
    • Rising Use of Sodium Chloride in Dialysis Solutions Expands Market Opportunity
    • Growth in IV Fluid Market Propels Demand for Pharmaceutical Grade Sodium Chloride
    • Advances in Purification Technologies Enhance Product Quality
    • Increasing Investment in Healthcare Infrastructure
    • Development of Biopharmaceuticals and Biosimilars
    • Expansion of Global Pharmaceutical Manufacturing
    • Rising Focus on Drug Formulation and Stability
    • Growth in Clinical Research and Trials
    • Increasing Applications in Oral Rehydration Solutions
    • Advances in Drug Delivery Systems Impacting Sodium Chloride Usage
    • Growth in Emerging Markets Expands Addressable Market Opportunity
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Oral Rehydration Salts (ORS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Pharmaceutical Grade Sodium Chloride Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION